Co-delivery of sorafenib and an FSP1 inhibitor triggers dual ferroptosis in tumor cells and immunosuppressive macrophages for enhanced immunotherapy in mouse models of hepatocellular carcinoma
Chuanyu Tang(National Instruments (Ireland)), Chihua Fang(Zhujiang Hospital)
Cited by 12